Take Five: Panic over? World markets themes for the week ahead
LONDON (Reuters) – Following are the five big themes likely to dominate thinking of investors and traders in the coming week and the Reuters stories related to them. FILE PHOTO:…
Asia shares sit on weekly gains, await U.S. jobs test
SYDNEY (Reuters) – Asian share markets consolidated weekly gains on Friday as Sino-U.S. talks dragged on with no concrete conclusions, while caution ahead of U.S. payrolls and a holiday in…
Tokyo prosecutors enter former Nissan chief Ghosn’s home: NHK
FILE PHOTO: Former Nissan Motor Chairman Carlos Ghosn sits inside a car as he leaves his lawyer’s office after being released on bail from Tokyo Detention House, in Tokyo, Japan,…
Exclusive: Renault alerts prosecutors to Oman dealer payments in Ghosn era
PARIS (Reuters) – Renault has alerted French prosecutors to payments made to a Renault-Nissan business partner in Oman under former Chief Executive Carlos Ghosn, two sources told Reuters. FILE PHOTO:…
U.S., China report progress in Beijing trade talks
BEIJING/PALM BEACH, Fla. (Reuters) – U.S. President Donald Trump said on Friday that trade talks with China were going very well, but cautioned that he would not accept anything less…
Nissan committee says facts point to legal violations by former chairman Ghosn
YOKOHAMA, Japan (Reuters) – An external committee reviewing governance at Nissan Motor Co said on Wednesday there were enough facts to suspect violations of laws and the private use of…
Beneath Fed’s positive spin, an embrace of a tepid future
SAN FRANCISCO/WASHINGTON (Reuters) – Federal Reserve policymakers see a U.S. economy that is rapidly losing momentum. They predict inflation will miss their 2 percent target for yet another year, despite…
Wall Street powers world stocks; dollar up on Brexit woes
NEW YORK (Reuters) – Wall Street led global stocks higher on Thursday on the back of upbeat economic data, while the dollar rallied despite the Federal Reserve’s uber-dovish stance as…
Biogen scraps two Alzheimer drug trials, wipes $18 billion from market value
CHICAGO/TOKYO (Reuters) – Biogen Inc and partner Eisai Co Ltd are ending two late-stage trials of their experimental Alzheimer’s disease drug aducanumab, a major setback in the quest to find…
With high-tech glasses, Japanese ALS patient makes the beat go on
TOKYO (Reuters) – The music booms and lights flash as Masatane Muto, a wheelchair-bound disc jockey, uses is eyes to put on a show at a recent Tokyo music festival.…